Arcadia Biosciences Inc expected to post a loss of $2.58 a share - Earnings Preview

Arcadia Biosciences

26/03/2024 20:45

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 28
for the period ending December 31 2023
    * The Davis California-based  company is expected to report
a
75.0% increase in revenue to $1.75 million from $1 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Arcadia Biosciences Inc
is for
a loss of $2.58 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $11.00​, above​ its last closing price
of $2.30. ​​​

This summary was machine generated March 26 at 20:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)